Investors / United States / AllerFund
AllerFund
Venture capital · New York, NY, United States · North America
AllerFund is a for-profit venture capital fund focused on the food allergy community. It invests in early-stage companies and works with scientists and entrepreneurs to build businesses around research and technologies, providing business advice and support.
Invests inHealthcare & BiotechFood & Agriculture
In its own wordsfood allergytherapeuticsmedical devicesdiagnosticsdigital healthconsumer products
Your fit with AllerFund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAllerFund lists 9 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (64%) and Food & Agriculture (36%). 100% of its companies are based in United States. It invests most often alongside A-Level Capital, ARTIS and Aglaé Ventures.
No funding round on record names AllerFund yet, so the figures come from its portfolio page.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 19th | 9 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 90th | 64% in its largest sector |
| Reach | 20th | 1 country |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers9100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 64% | 15% |
| Food & Agriculture | 36% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare AllerFund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
9 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Allergy Amulet develops a small and fast food allergen sensor to detect allergenic ingredients in food | Healthcare & Biotech | Portfolio page | ||
| Anjo provides a platform that analyzes physiological signals and delivers remote monitoring, early detection and personalized allergy insights for families and individuals living with life-threatening allergies | Healthcare & Biotech | Portfolio page | ||
| EvoEndo develops and provides a single-use unsedated endoscopy system for patients of all ages | Healthcare & Biotech | Portfolio page | ||
| Fig is an app that shows users what foods they can eat based on their dietary needs and restrictions | Food & AgricultureHealthcare & Biotech | Portfolio page | ||
| Yumi produces and sells healthy snacks for toddlers and families | Food & Agriculture | Portfolio page | ||
| IgGenix is a clinical-stage antibody discovery and development company that solves allergies and other immunological diseases. | Healthcare & Biotech | Portfolio page | ||
| Latitude provides food allergy testing and treatment services, including oral immunotherapy, to patients. | Healthcare & Biotech | Portfolio page | ||
| LiberEat provides automated food compliance software to detect errors in product or menu data for the food sector | Food & AgricultureFood & Agriculture | Portfolio page | ||
| Moonlight Therapeutics is developing a new skin based therapy to transform the lives of people living with food allergies | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- allerfund.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 9
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get AllerFund's profile as data
Pull AllerFund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/allerfund.com
# also
GET /v1/firms/allerfund.com/portfolio
GET /v1/firms/allerfund.com/coinvestors
GET /v1/firms/allerfund.com/news